Palatal Crib Versus Bonded Spurs in Early Treatment of Anterior Open Bite Caused by Non-nutritive Sucking Habits: RCT
Launched by REEM HATEM SHAMS · Apr 1, 2022
Trial Information
Current as of July 25, 2025
Unknown status
Keywords
ClinConnect Summary
Habit is an unintentionally performed repeated activity. Development of habit is considered a part of the natural progression of maturation in children between infancy and three years of age, after this period, it is assumed to be unnatural. The most familiar and earliest noted habit is thumb sucking. It develops during infancy as a rooting reflex, after it ceases around three years of age .
Thumb sucking is defined as the placement of the thumb or one or more fingers in different depths into the mouth ). It emerges in two forms: nutritive and non-nutritive, where the first gives nourishme...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Children with nonnutritive sucking habits and/or tongue thrusting from 6 years to 11 years old.
- • 2. Angle Class I malocclusions.
- • 3. Anterior open bite equal to or greater than 1 mm.
- • 4. Maxillary and mandibular permanent central incisors fully erupted (children in the first transitional period were eligible for treatment when the maxillary lateral incisors were beginning to erupt, and the maxillary central incisors were still showing an open bite).
- Exclusion Criteria:
- • 1. Children with loss of permanent teeth.
- • 2. Crowding, maxillary constriction, or posterior crossbites.
- • 3. Previous orthodontic treatment.
- • 4. Presence of craniofacial anomalies or syndromes.
- • 5. Tooth agenesis.
About Reem Hatem Shams
Reem Hatem Shams is a dedicated clinical trial sponsor committed to advancing medical research and innovation. With a focus on enhancing patient outcomes, the organization specializes in the design, management, and execution of clinical trials across various therapeutic areas. Leveraging a robust network of healthcare professionals and research institutions, Reem Hatem Shams prioritizes ethical standards, regulatory compliance, and patient safety throughout the research process. The sponsor’s mission is to contribute to the development of effective treatments while fostering collaboration within the scientific community to address unmet medical needs.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Ahmed H Elkhadem, Ass. professor
Study Chair
Cairo University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials